(Q38434716)

3 September 2017

Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs (English)

1 reference

3 September 2017

1 reference

Fasciola hepatica

1 reference

L Alvarez

1

1 reference

3 September 2017

G Moreno

2

1 reference

3 September 2017

L Moreno

3

1 reference

3 September 2017

L Ceballos

4

1 reference

3 September 2017

L Shaw

5

1 reference

3 September 2017

I Fairweather

6

1 reference

3 September 2017

C Lanusse

7

1 reference

3 September 2017

20 May 2009

1 reference

3 September 2017

Veterinary Parasitology

1 reference

3 September 2017

164

1 reference

3 September 2017

2-4

1 reference

3 September 2017

211-216

1 reference

In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

2000 Report of the AVMA Panel on Euthanasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Benzimidazoles: veterinary uses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

The detection of anthelmintic resistance in nematodes of veterinary importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Fasciolicides: efficacy, actions, resistance and its management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Triclabendazole: new skills to unravel an old(ish) enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Triclabendazole progress report, 2005-2009: an advancement of learning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

The metabolism of benzimidazole anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

The kinetics of triclabendazole disposition in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Comparison of inhibition of polymerisation of mammalian tubulin and helminth ovicidal activity by benzimidazole carbamates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Mode of action of benzimidazoles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Specific interaction of benzimidazole anthelmintics with tubulin from developing stages of thiabendazole-susceptible and -resistant Haemonchus contortus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

The benzimidazole anthelmintic agents--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Effect of fenbendazole and ivermectin on development of strongylate nematode eggs and larvae in calf feces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

A new in vitro assay of benzimidazole activity against adult Oesophagostomum dentatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Metabolite concentrations in plasma following treatment of cattle with five anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

Benzimidazoles and fluke eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2009.05.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETPAR.2009.05.014

1 reference

3 September 2017

1 reference